Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024		30,202,003
Balance at beginning of period at Dec. 31, 2024	$ 1,226,061	$ 298	$ 384,932	$ 982,304	$ (141,473)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	(135,613)			(135,613)
Other comprehensive income (loss), net of tax	43,659				43,659
Stock-based compensation expense	5,227		5,227
Issuance of common stock under share-based compensation arrangements (in shares)		149,718
Issuance of common stock under share-based compensation arrangements	(1,160)	$ 2	(1,162)
Issuance of common stock related to employee stock purchase plan (in shares)		14,834
Issuance of common stock related to employee stock purchase plan	308		308
Cash dividends declared	(15,006)			(15,006)
Ending balance (in shares) at Sep. 30, 2025		30,366,555
Balance at end of period at Sep. 30, 2025	1,123,476	$ 300	389,305	831,685	(97,814)
Beginning balance (in shares) at Jun. 30, 2025		30,364,983
Balance at beginning of period at Jun. 30, 2025	1,185,067	$ 300	388,927	904,205	(108,365)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	(67,513)			(67,513)
Other comprehensive income (loss), net of tax	10,551				10,551
Stock-based compensation expense	1,430		1,430
Issuance of common stock under share-based compensation arrangements (in shares)		(4,000)
Issuance of common stock under share-based compensation arrangements	(1,160)		(1,160)
Issuance of common stock related to employee stock purchase plan (in shares)		5,572
Issuance of common stock related to employee stock purchase plan	108		108
Cash dividends declared	(5,007)			(5,007)
Ending balance (in shares) at Sep. 30, 2025		30,366,555
Balance at end of period at Sep. 30, 2025	$ 1,123,476	$ 300	389,305	831,685	(97,814)
Beginning balance (in shares) at Dec. 31, 2025	30,359,632	30,359,632
Balance at beginning of period at Dec. 31, 2025	$ 1,131,283	$ 300	382,499	837,643	(89,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	45,882			45,882
Other comprehensive income (loss), net of tax	(23,637)				(23,637)
Stock-based compensation expense	6,930		6,930
Issuance of common stock under share-based compensation arrangements (in shares)		105,047
Issuance of common stock under share-based compensation arrangements	(1,495)	$ 2	(1,378)	(119)
Issuance of common stock related to employee stock purchase plan (in shares)		15,801
Issuance of common stock related to employee stock purchase plan	354		354
Cash dividends declared	$ (916)			(916)
Ending balance (in shares) at Sep. 30, 2026	30,480,480	30,480,480
Balance at end of period at Sep. 30, 2026	$ 1,158,401	$ 302	388,405	882,490	(112,796)
Beginning balance (in shares) at Jun. 30, 2026		30,490,409
Balance at beginning of period at Jun. 30, 2026	1,150,506	$ 302	385,082	858,601	(93,479)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	24,246			24,246
Other comprehensive income (loss), net of tax	(19,317)				(19,317)
Stock-based compensation expense	3,466		3,466
Issuance of common stock under share-based compensation arrangements (in shares)		(15,993)
Issuance of common stock under share-based compensation arrangements	(348)		(296)	(52)
Issuance of common stock related to employee stock purchase plan (in shares)		6,064
Issuance of common stock related to employee stock purchase plan	153		153
Cash dividends declared	$ (305)			(305)
Ending balance (in shares) at Sep. 30, 2026	30,480,480	30,480,480
Balance at end of period at Sep. 30, 2026	$ 1,158,401	$ 302	$ 388,405	$ 882,490	$ (112,796)